Hand Transplantation for Amputation
This study is investigating hand transplantation, a surgery that transfers tissue from a non-living donor to a living individual. The goal is to see if this procedure can help people who have lost all or part of one or both hands and forearms regain better function, appearance, and feeling. Researchers will also collect information on how patients recover and what their outcomes are after the transplant. You may be able to join if you are between 18 and 60 years old, are missing part of your hand or forearm due to injury, and are HIV negative. The study will measure how many people experience biopsy-proven rejection (when the body's immune system attacks the new hand) over 60 months.
- Study design
- This is an interventional study planning to enroll 100 participants. It is designed to evaluate the effects of hand transplantation.
- What's involved
- You would undergo pre-transplant screening procedures and evaluations, which are re-evaluated yearly if you are on the waiting list. If on the waitlist, you would provide serum samples monthly for cross-matching.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 60 months to monitor for biopsy-proven rejection.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Hand Transplantation
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sheel Sharma, MD · PRINCIPAL_INVESTIGATOR · NYU Langone Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number and proportion of subjects with biopsy-proven rejection60 months